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doi:10.1016/j.kjms.2011.10.028Abstract Although pulmonary small cell carcinoma (SCC) is seen frequently, SCC that origi-
nates from the extrapulmonary organs is extremely rare. We herein report a case of a SCC
located in the lesser omentum. A 61-year-old male was admitted to our department due to
intermittent epigastralgia for 2 months. Ultrasonography (US) revealed an irregular hypoechoic
mass measuring about 58 mm  50 mm  45 mm under the left lobe of the liver. Magnetic reso-
nance imaging (MRI) was performed to verify the irregular mass with T1- and T2- weighted
images between the left lobe of liver and the stomach. At laparotomy, the well-
circumscribed neoplasm was found in the lesser omentum, and the fundus of the neoplasm
was located in the root of left gastric artery. Intraoperative microscopic evaluation of frozen
sections revealed malignancy of the lesser omentum. Resection of the neoplasm was per-
formed, and the combined resection of the vagal nerve was also performed for the partial
adhesion. Pyloroplasty was performed for avoiding delayed gastric emptying caused by
combined resection of vagal nerve. The lymph nodes dissection at lesser curvature and right
cardia was also performed with a negative result. Based on the histological findings, the final
diagnosis of primary lesser omental SCC was confirmed. The pathologic staging showed locor-
egional disease.
Copyright ª 2011, Elsevier Taiwan LLC. All rights reserved.of General Surgery, Dongnan
y, No. 269, Zhanghua Middle
J. Liu).
vier Taiwan LLC. All rights reservIntroduction
Extrapulmonary small cell carcinomas (EPSCCs) are
uncommon neoplasms when compared with those of
pulmonary origin, accounting for approximately 2.5e5% of
those pulmonary small cell carcinomas (PSCCs) [1,2]. Since
the initial EPSCC was reported by Duguid and Kennedy in
1930 [3], more and more cases of EPSCC have beened.
116 J.-F. Feng et al.described in various organs. We herein report a case of
a lesser omental SCC.
Case presentation
A 61-year-old male was admitted to our department due to
intermittent epigastralgia for 2 months. He denied any
history of blood transfusion, alcohol abuse or medications.
His past clinical history and family history were all normal.
He was a non-smoker. Physical examination was unre-
markable. On admission, serum levels of a-fetoprotein
(AFP), carcinoembryonic antigen (CEA) and cancer antigen
19-9 (CA19-9) were all normal. Ultrasonography (US)
revealed an irregular hypoechoic mass measuring about
58 mm  50 mm  45 mm under the left lobe of liver
(Fig. 1). Magnetic resonance imaging (MRI) was performed
to verify the irregular mass with T1- and T2- weighted
images between the left lobe of liver and the stomach
(Fig. 2). The result of the chest computer radiography (CR)
and electrocardiogram (ECG) were all normal.
At laparotomy, the well-circumscribed neoplasm was
found in the lesser omentum, and the fundus of the
neoplasm located in the root of left gastric artery. Intra-
operative microscopic evaluation of frozen sections
revealed malignancy of the lesser omentum. Excision of the
neoplasm was performed, and the excision of partial trun-
cal vagus nerve was also performed for partial adhesion.
Pyloroplasty was performed for avoiding delayed gastric
emptying caused by combined resection of the vagal nerve.
The lymph nodes dissection at lesser curvature and right
cardia was also performed, with a negative result. Histo-
logical examination revealed that the tumor is composed of
small cells with scant eosinophilic cytoplasm, oval to
spindle-shaped nuclei with stippled nuclear chromatin, and
inconspicuous nucleoli (Fig. 3AeB). ImmunohistochemistryFigure 1. US revealed an irregular hypoechoic mass measuring
(LL:left liver, M:mass).revealed the tumor cells were positive for CD56 (Fig. 3C),
cytokeratin (CK) (Fig. 3D), synaptophysin (Syn) and neuron-
specific enolase (NSE). Based on the histological findings,
the final diagnosis of primary lesser omental SCC was
confirmed. The pathologic staging showed locoregional
disease. Adjuvant chemotherapy with the CMV regimen
consisting of cisplatin 10 mg/m2 on days 1e5 combined with
methotrexate 20 mg/m2 and vincristine 1.4 mg/m2 on day 1
every 28 days for six courses was administered. The follow-
up abdominal US and chest CR were all normal during the
period of adjuvant chemotherapy. The patient was
followed-up in the out-patient department at regular
intervals.
The patient was admitted to our department again
20 months later due to the upper abdominal discomfort for
1 month. Results of abdominal US and chest CR were all
normal. Gastroscopy was performed, and the results
revealed cardiac and fundic carcinoma. According to
previous medical history, metastatic carcinoma of the
lesser omental SCC was suspected. Histological examina-
tion of the endoscopic biopsy specimens confirmed our
suspicion. However, at this time, the patient refused an
operation. On admission, chemotherapy with the OLF
regimen consisting of oxaliplatin 85 mg/m2 on day 1
combined with leucovorin calcium 100 mg/m2 and 5-fluo-
rouracil 250 mg/m2 on days 1e5 every 28 days was admin-
istered. After 4 cycles of combination chemotherapy,
metastasis of the liver was found by the US and CT. The
patient died 2 months later due to widespread metastasis.
The total survival time of our patient was 26 months.
Disscussion
EPSCCs are rare, with an incidence of between 0.1e0.4% of
all cancers [2]. The incidence of EPSCCs compared withabout 58 mm  50 mm  45 mm under the left lobe of liver.
Figure 2. MRI was performed to verify the irregular mass (white arrow head) with coronal (A) and axial (B) T2- and coronal
(C) and axial (D) T1- weighted images between the left lobe of liver and stomach.
Lesser omental SCC 117those of pulmonary SCCs are very low, accounting for
approximately 2.5% to 5% of those pulmonary small cell
carcinomas (PSCCs) [1,2]. In a series of cases of EPSCCs
reviewed, the most common sites were the gastrointestinal
and genitourinary tract [4e6]. Primary EPSCC has been
described in different organs, including pleura [7,8],
thymus [2,4,8], kidney [8,9], bladder [2,4], prostate [10,11],
epididymis [12], endometrium [2], uterine cervix [2,13],
ovary [2,4], salivary glands [1,2,4], sinuses [2,4,14], larynx
[1], trachea [1], thyroid [4], lymph node [4,15], central
nervous system [4], bone [15,16], skin [1,15], peritoneum
[4], stomach [4e6,11], esophagus [2,17], liver [4,15], gall-
bladder [18], pancreas [11,15], appendix [19], and color-
ectum [4,6,20]. Primary peritoneal carcinomas are relatively
rare [21]. Galanis E et al. [4] previously reported a primary
EPSCC in the pelvic peritoneum, while primary SCC of the
lesser omentum has not yet been reported in the English
language literature.
The specific risk factors for the development of EPSCC
have not been identified, although these appear similar to
those predisposing to the development of other types of
carcinomas in the same organ. Although smoking is clearly
implicated in the formation of PSCC [22], its association
with EPSCC is not clearly documented [4,5,23]. In addition,
pleural EPSCC has occurred following a history of asbestos
exposure in some cases [24]. In our case, the patient was
a non-smoker with a normal clinical and family history.
Accordingly, smoking was not a causative role for his lesser
omental SCC.Irrespective of the sites of origin, SCCs share distinctive
histochemical features [25]. Histologically, these tumors
are composed of small cells with scant eosinophilic cyto-
plasm, oval to spindle-shaped nuclei with stippled nuclear
chromatin, and inconspicuous nucleoli. Mitotic figures and
areas of prominent necrosis are frequently seen [26].
EPSCC, which shares immunohistochemical similarity with
PSCC, usually shows strong and diffuse immunoreactivity
for CD56 [27,28]. In our case, immunohistochemistry
revealed that the tumor cells were positive for CD56, CK,
Syn and NSE. In the absence of a lung primary combined
with the histological findings, the final diagnosis of primary
lesser omental SCC was confirmed. Preoperative diagnosis
was difficult, because EPSCC of the lesser omentum was
extremely rare, which has not yet been reported in the
English language literature.
Treatment strategies are varied and include surgical,
chemotherapeutic, radiotherapeutic, and combined ap-
proaches. However, chemotherapy, either alone or as part
of a combined approach, has emerged as the cornerstone
of treatment [4,29,30]. Brenner et al. [31] indicated that
chemotherapy can achieve significant palliation, surgery,
may have a potential impact on long-term survival of
patients with locoregional disease. Various chemothera-
peutic drug combinations have been tried, mostly including
cisplatin, etoposide, cyclophosphamide, or doxorubicin as
the main agent. Response rates of up to 70% have been
reported, with the best responses seen with the platinum-
based regimens [31,32]. In our case, the lesser omental
Figure 3. Histological examination revealed the tumor is composed of small cells with scant eosinophilic cytoplasm, oval to
spindle-shaped nuclei with stippled nuclear chromatin, and inconspicuous nucleoli (Hematoxylin-eosin stain: Fig. 3A 40, Fig. 3B
200). Immunohistochemistry revealed the tumor cells were positive for CD56 (Fig. 3C) and CK (Fig. 3D). (200)
118 J.-F. Feng et al.neoplasm was well-circumscribed. Therefore, we per-
formed the surgery with, also, platinum-based regimens as
per reported literatures with the best responses [31].
The prognosis for EPSCC is similar to PSCC, and remains
poor, with a rapidly deteriorating clinical course. Five-year
survival is <15%, although some patients enjoy a prolonged
survival [4,5,33]. The mean survival for gastrointestinal
EPSCC is less than 5 months with a 3 and 8 month mean
survival for extensive and localized disease, respectively
[34]. In our case, the total survival was 26 months after the
initial surgery and adjuvant chemotherapy.
In conclusion, we herein report a case of a primary
EPSCC of the lesser omentum. Although lesser omental SCC
is difficult to diagnose before treatment, we believe that
careful examination, including immunohistochemical anal-
ysis, is necessary to determine the therapeutic strategy.
Although a standard treatment for lesser omental SCC has
not been established, intensive chemotherapy with
platinum-based regimens is effective in the treatment of
primary EPSCC.References
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